Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Novartis Pharmaceuticals · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
copdnapulmonary-disease
pulmonary disease, chronic obstructive (copd), copd, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 966424
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.